Abbott
Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent
Published in Health Business Week, March 28th, 2008
Abbott (NYSE:ABT) announced that it has received CE Mark (Conformite Europeene) approval for a 2.25 mm version of its XIENCE(TM) V Everolimus Eluting Coronary Stent System, offering physicians a smaller stent based upon the proven efficacy, positive safety results and excellent deliverability of XIENCE V. The addition of the 2.25 mm stent to the XIENCE V portfolio gives physicians access to a wider range of stent sizes for treating a variety of patient types.
"Lesions in small vessels tend to be more complex and challenging to treat, so it's important to have a drug eluting stent with proven clinical benefits that can be easily delivered to the diseased area of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2008-03-28)
More Articles from Health Business Week
- 1 Beyond(TM), Inc.
1 Beyond Unveils New Ruggedized HD Editing System for Broadcast Trucks - A Place of Hope.com
A Place of Hope.com Emphasizes the Whole-Person Approach to Therapy - AARP
AARP Services Inc. and Genworth Financial Introduce New Innovative and Affordable Long Term Care Insurance Option to AARP Members - AARP
Coalition of Consumer, Business, Union and Advocacy Groups Call for Increased Rx Affordability and Accessibility - Abox Publishing
Push-ups, 'The New Fitness Nirvana' - ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals to Present at Lehman Brothers 11th Annual Global Healthcare Conference - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
